๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers

โœ Scribed by Desai, Monica Dandona; Saroya, Bikramajit Singh; Lockhart, Albert Craig


Book ID
120223634
Publisher
Informa plc
Year
2013
Tongue
English
Weight
421 KB
Volume
22
Category
Article
ISSN
1354-3784

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Drugs for HER-2-positive Breast Cancer V
โœ Sibilia, Maria; Zielinski, Christoph C.; Bartsch, Rupert; Grunt, Thomas W. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Springer Basel ๐ŸŒ German โš– 425 KB

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory